Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderate to Severe Hidradenitis Suppurativa

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety o... Read More


Singapore Clinical Trial: A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Parti... Read More


Singapore Clinical Trial: Prospective randomised controlled evaluation of Tetracycline ointment for preventing infections in uncomplicated soft-tissue wounds repaired in the emergency department – a pilot study.

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'Prospective randomised controlled evaluation of Tetracycline ointment for preventing infections in u... Read More


Singapore Clinical Trial: Role of glucagon-like peptide 1 receptor Agonist (GLP1 RA) Dulaglutide on cerebral hemodynamics In patients with severe and symptomAtic steNosis of inTracranial internal carotid artery or middle cerebral artery with impaired cerebral vasodilatory reserve- an open-label randomised clinical trial (RADIANT)

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'Role of glucagon-like peptide 1 receptor Agonist (GLP1 RA) Dulaglutide on cerebral hemodynamics In p... Read More


Singapore Clinical Trial: A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the effica... Read More


Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adi... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Dulaglutide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Dulaglutide on Retai... Read More


Oil's price boom foreshadows a post-war bust

Dhaka, May 1 -- Right now, oil investors' main obsession is excessively high prices. Fair enough: the effective closure of the Strait of Hormuz since early March has sent Brent crude as high as $126 a... Read More


Sudarshan Pharma Q4 net profit up 35.70% at Rs 9.54 cr

India, May 1 -- The company reported standalone net profit of Rs 9.54 crore for the quarter ended March 31, 2026 as compared to Rs 7.03 crore in the same period last year, registering a year-on-year g... Read More


Servotech Renewable Q4 net profit jumps 49.43% at Rs 11.73 cr

India, May 1 -- The company reported standalone net profit of Rs 11.73 crore for the quarter ended March 31, 2026 as compared to Rs 7.85 crore in the same period last year, registering a year-on-year ... Read More